These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
768 related articles for article (PubMed ID: 26363006)
1. A TDO2-AhR signaling axis facilitates anoikis resistance and metastasis in triple-negative breast cancer. D'Amato NC; Rogers TJ; Gordon MA; Greene LI; Cochrane DR; Spoelstra NS; Nemkov TG; D'Alessandro A; Hansen KC; Richer JK Cancer Res; 2015 Nov; 75(21):4651-64. PubMed ID: 26363006 [TBL] [Abstract][Full Text] [Related]
2. An Aryl Hydrocarbon Receptor-Mediated Amplification Loop That Enforces Cell Migration in ER-/PR-/Her2- Human Breast Cancer Cells. Novikov O; Wang Z; Stanford EA; Parks AJ; Ramirez-Cardenas A; Landesman E; Laklouk I; Sarita-Reyes C; Gusenleitner D; Li A; Monti S; Manteiga S; Lee K; Sherr DH Mol Pharmacol; 2016 Nov; 90(5):674-688. PubMed ID: 27573671 [TBL] [Abstract][Full Text] [Related]
3. Tryptophan metabolism induced by TDO2 promotes prostatic cancer chemotherapy resistance in a AhR/c-Myc dependent manner. Li F; Zhao Z; Zhang Z; Zhang Y; Guan W BMC Cancer; 2021 Oct; 21(1):1112. PubMed ID: 34657603 [TBL] [Abstract][Full Text] [Related]
4. Lung cancer-derived galectin-1 contributes to cancer associated fibroblast-mediated cancer progression and immune suppression through TDO2/kynurenine axis. Hsu YL; Hung JY; Chiang SY; Jian SF; Wu CY; Lin YS; Tsai YM; Chou SH; Tsai MJ; Kuo PL Oncotarget; 2016 May; 7(19):27584-98. PubMed ID: 27050278 [TBL] [Abstract][Full Text] [Related]
5. Reversal of Triple-Negative Breast Cancer EMT by miR-200c Decreases Tryptophan Catabolism and a Program of Immunosuppression. Rogers TJ; Christenson JL; Greene LI; O'Neill KI; Williams MM; Gordon MA; Nemkov T; D'Alessandro A; Degala GD; Shin J; Tan AC; Cittelly DM; Lambert JR; Richer JK Mol Cancer Res; 2019 Jan; 17(1):30-41. PubMed ID: 30213797 [TBL] [Abstract][Full Text] [Related]
6. Targeting of neuroblastoma cells through Kynurenine-AHR pathway inhibition. Dos Santos IL; Mitchell M; Nogueira PAS; Lafita-Navarro MC; Perez-Castro L; Eriom J; Kilgore JA; Williams NS; Guo L; Xu L; Conacci-Sorrell M FEBS J; 2024 May; 291(10):2172-2190. PubMed ID: 38431776 [TBL] [Abstract][Full Text] [Related]
7. PRKCQ promotes oncogenic growth and anoikis resistance of a subset of triple-negative breast cancer cells. Byerly J; Halstead-Nussloch G; Ito K; Katsyv I; Irie HY Breast Cancer Res; 2016 Sep; 18(1):95. PubMed ID: 27663795 [TBL] [Abstract][Full Text] [Related]
8. TDO2 knockdown inhibits colorectal cancer progression via TDO2-KYNU-AhR pathway. Zhao L; Wang B; Yang C; Lin Y; Zhang Z; Wang S; Ye Y; Shen Z Gene; 2021 Aug; 792():145736. PubMed ID: 34051337 [TBL] [Abstract][Full Text] [Related]
9. Targeting the IDO1/TDO2-KYN-AhR Pathway for Cancer Immunotherapy - Challenges and Opportunities. Cheong JE; Sun L Trends Pharmacol Sci; 2018 Mar; 39(3):307-325. PubMed ID: 29254698 [TBL] [Abstract][Full Text] [Related]
10. Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling. Jiang HL; Sun HF; Gao SP; Li LD; Hu X; Wu J; Jin W Oncotarget; 2015 Jun; 6(18):16352-65. PubMed ID: 25970785 [TBL] [Abstract][Full Text] [Related]
11. MED12 mutation activates the tryptophan/kynurenine/AHR pathway to promote growth of uterine leiomyomas. Zuberi A; Huang Y; Dotts AJ; Wei H; Coon JS; Liu S; Iizuka T; Wu O; Sotos O; Saini P; Chakravarti D; Boyer TG; Dai Y; Bulun SE; Yin P JCI Insight; 2023 Sep; 8(18):. PubMed ID: 37607000 [TBL] [Abstract][Full Text] [Related]
12. Stemness and immune evasion conferred by the TDO2-AHR pathway are associated with liver metastasis of colon cancer. Miyazaki T; Chung S; Sakai H; Ohata H; Obata Y; Shiokawa D; Mizoguchi Y; Kubo T; Ichikawa H; Taniguchi H; Aoki K; Soga T; Nakagama H; Okamoto K Cancer Sci; 2022 Jan; 113(1):170-181. PubMed ID: 34714577 [TBL] [Abstract][Full Text] [Related]
13. EWS-FLI1 impairs aryl hydrocarbon receptor activation by blocking tryptophan breakdown via the kynurenine pathway. Mutz CN; Schwentner R; Kauer MO; Katschnig AM; Kromp F; Aryee DN; Erhardt S; Goiny M; Alonso J; Fuchs D; Kovar H FEBS Lett; 2016 Jul; 590(14):2063-75. PubMed ID: 27282934 [TBL] [Abstract][Full Text] [Related]
14. The Alternative Splicing of Cytoplasmic Polyadenylation Element Binding Protein 2 Drives Anoikis Resistance and the Metastasis of Triple Negative Breast Cancer. Johnson RM; Vu NT; Griffin BP; Gentry AE; Archer KJ; Chalfant CE; Park MA J Biol Chem; 2015 Oct; 290(42):25717-27. PubMed ID: 26304115 [TBL] [Abstract][Full Text] [Related]
15. Knockdown of endothelin receptor B inhibits the progression of triple-negative breast cancer. Gu X; Han S; Cui M; Xue J; Ai L; Sun L; Zhu X; Wang Y; Liu C Ann N Y Acad Sci; 2019 Jul; 1448(1):5-18. PubMed ID: 30900271 [TBL] [Abstract][Full Text] [Related]
16. The matricellular protein CYR61 promotes breast cancer lung metastasis by facilitating tumor cell extravasation and suppressing anoikis. Huang YT; Lan Q; Lorusso G; Duffey N; Rüegg C Oncotarget; 2017 Feb; 8(6):9200-9215. PubMed ID: 27911269 [TBL] [Abstract][Full Text] [Related]
17. A novel long non-coding RNA linc-ZNF469-3 promotes lung metastasis through miR-574-5p-ZEB1 axis in triple negative breast cancer. Wang PS; Chou CH; Lin CH; Yao YC; Cheng HC; Li HY; Chuang YC; Yang CN; Ger LP; Chen YC; Lin FC; Shen TL; Hsiao M; Lu PJ Oncogene; 2018 Aug; 37(34):4662-4678. PubMed ID: 29755127 [TBL] [Abstract][Full Text] [Related]
19. Disulfiram induces anoikis and suppresses lung colonization in triple-negative breast cancer via calpain activation. Kim JY; Lee N; Kim YJ; Cho Y; An H; Oh E; Cho TM; Sung D; Seo JH Cancer Lett; 2017 Feb; 386():151-160. PubMed ID: 27894956 [TBL] [Abstract][Full Text] [Related]
20. Investigation of the aryl hydrocarbon receptor and the intrinsic tumoral component of the kynurenine pathway of tryptophan metabolism in primary brain tumors. Guastella AR; Michelhaugh SK; Klinger NV; Fadel HA; Kiousis S; Ali-Fehmi R; Kupsky WJ; Juhász C; Mittal S J Neurooncol; 2018 Sep; 139(2):239-249. PubMed ID: 29667084 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]